Skip survey header
PQCNC Logo

PQCNC AIM OUD State of the State

PQCNC OUD State of the State

This question requires a valid date format of MM/DD/YYYY.
calendar
This question requires a valid email address.
8. Who delivers your outpatient prenatal care: (select all that apply): *This question is required.
9. Does your outpatient prenatal care clinic staff perform hospital deliveries?   *This question is required.
11. Does your outpatient prenatal care clinic implement a universal screening protocol for substance use in pregnancy?   *This question is required.
Is the Universal Screening utilizing verbal/written or urine toxicology, or both? *This question is required.
12. Does your outpatient prenatal care clinic staff provide medication assisted treatment (Buprenorphine) for pregnant women with OUD?   *This question is required.
Are women connected or referred to additional SUD treatment services, counseling or therapy?  *This question is required.
13. Is there education and delivery planning available for pregnant women with OUD specific to the concerns around delivery and risk for NAS already in place?   *This question is required.
Is the education and plan differentiated based on if she has an OUD and is in recovery with MAT, versus an untreated OUD?   *This question is required.
15. Our units have a QI team.   *This question is required.
16. Our clOUDi Initiative team has active / engaged patients and family members.   *This question is required.
17. Our clOUDi Initiative team has a member of senior leadership: *This question is required.
20. Has your hospital implemented a universal verbal screening protocol for substance use disorders including opioid use disorder?  *This question is required.
22. Does your hospital have a protocol that guides providers in how to respond to a positive opioid use screen?  *This question is required.
23. Does your hospital have a protocol for inducting women onto medication to treat opioid use disorder?  *This question is required.
24. Does your hospital have a protocol for ensuring that women already taking medication to treat opioid use disorder can receive their medication without interruption during their hospital stay?  *This question is required.
25. Has your hospital implemented a policy and procedure to improve the rates of women with OUD returning for their post-partum care appointment?  *This question is required.
26. Has your hospital implemented post-delivery and discharge pain management prescribing practices for routine vaginal and cesarean births focused on limiting opioid prescriptions?  *This question is required.
27. Has your hospital implemented specific pain management and opioid prescribing guidelines for OUD patients?  *This question is required.
28. Has your hospital implemented a policy and protocol that supports women receiving medication to treat opioid use disorder to breastfeed?   *This question is required.
Thinking about current practices around OUD at your facility:
 
29. Medication-assisted treatment is understood and accepted as an evidence-based treatment for pregnant women who have an opioid use disorder *This question is required.
30. Policy and protocols that facilitate access to medication assisted treatment for pregnant women with opioid use disorders are in place (e.g. priority access; policies that state that pregnant women should not receive medication-assisted treatment; mutual aid groups that do not support medication-assisted treatment).  *This question is required.
31. Our approach is guided by principles that are evidence-based and trauma informed.  *This question is required.
32. Our approach is culturally responsive *This question is required.
33. Our facility has a good working relationship with the other key agencies.  *This question is required.
34. A formalized system of care coordination between systems is in place (e.g., information sharing agreements, MOUs).  *This question is required.
35. All pregnant women with substance use disorders are identified.   *This question is required.
36. Medication-assisted treatment for pregnant women is available *This question is required.
37. Specialized prenatal care (e.g., obstetricians who are knowledgeable in addiction medicine) is available for pregnant women with opioid use disorders.   *This question is required.
38. The appropriate levels of care (e.g., residential substance use treatment programs) for pregnant women are available.   *This question is required.
39. The full range of services (e.g., individual and group counseling, residential, etc.) is provided in conjunction with medication assisted treatment.   *This question is required.
40. Newborns and infants who have been prenatally exposed to opioids are identified. *This question is required.
41. Ongoing care and monitoring is available for infants who have been prenatally exposed to opioids.   *This question is required.
42. Policies are in place to assist pregnant women who have financial obstacles when trying to access and maintain services for the treatment of opioid use disorders (e.g., medication-assisted treatment; outpatient or residential treatment; individual and group counseling; other services).   *This question is required.
43. Priority and preferred access* to substance use treatment and medication-assisted treatment for pregnant women is enforced.

*As required by the Substance Abuse Prevention and Treatment Block Grant and opioid treatment program certification standards.   *This question is required.
44. There are policies in place to address funding obstacles in providing ongoing care (e.g., following hospital discharge) to infants who are prenatally exposed.   *This question is required.
45. The core service providers (i.e., mother’s medical providers, infant’s medical providers, substance use and medication assisted treatment) are knowledgeable on the treatment of opioid use disorder in pregnancy and on the care and treatment of prenatally exposed infants *This question is required.
46. Partners have a shared understanding of outcomes that includes both the mother and the infant (e.g., the overall goal includes mother, infant, and family well-being).   *This question is required.
47. Data is tracked and shared between systems to monitor outcomes.   *This question is required.
48. Programs and core service providers have implemented quality assurance methods.   *This question is required.
49. Please select which service providers for the pregnant women you serve are knowledgeable about and provide evidence based perinatal substance use care *This question is required.
Thinking about equity:
50. Does your facility provide staff-wide education on peripartum racial and ethnic disparities and their root causes?  *This question is required.
51. Does your facility provide staff-wide education on best practices for shared decision making?   *This question is required.
52. Does your facility provide staff-wide education on implicit bias?   *This question is required.
53. Does your facility engage diverse patient, family, and community advocates who can represent important community partnerships on quality and safety leadership teams?   *This question is required.
54. Has your facility built a culture of equity, including systems for reporting, response, and learning similar to ongoing efforts in safety culture?   *This question is required.
55. Has your facility established a mechanism for patients, families, and staff to report inequitable care and episodes of miscommunication or disrespect?   *This question is required.
56. Does your facility ensure a timely and tailored response to each report of inequity or disrespect?   *This question is required.
57. Has your facility developed a disparities dashboard that monitors process and outcome metrics stratified by race and ethnicity, with regular dissemination of the stratified performance data to staff and leadership?   *This question is required.